Literature DB >> 24138209

Activation of proteinase-activated receptor 2 prevents apoptosis of lung cancer cells.

Shao-hong Huang1, Yun Li, Hui-guo Chen, Jian Rong, Sheng Ye.   

Abstract

The therapeutics of lung cancer (LC) is unsatisfactory. The pathogenesis of LC remains unclear. Protease-activated receptors (PAR) are involved in the immunoregulation. The present study aims to investigate the activation of PAR2 in regulation of the expression of EGFR and apoptosis of LC cells. The results showed that exposure to tryptase increased EGFR expression in A549 cells and suppressed the cell apoptosis. Tryptase also decreased the expression of Bax and increased Bcl-xL levels in A549 cells. We conclude that activation of PAR2 by tryptase can decrease the ratio of Bax/Bcl-xL and reduce the LC cell line, A549 cells, and apoptosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24138209     DOI: 10.3109/07357907.2013.845674

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  7 in total

1.  PRSS21/testisin inhibits ovarian tumor metastasis and antagonizes proangiogenic angiopoietins ANG2 and ANGPTL4.

Authors:  Gregory D Conway; Marguerite S Buzza; Erik W Martin; Nadire Duru; Tierra A Johnson; Raymond J Peroutka; Nisha R Pawar; Toni M Antalis
Journal:  J Mol Med (Berl)       Date:  2019-03-25       Impact factor: 4.599

2.  PAR2-dependent activation of GSK3β regulates the survival of colon stem/progenitor cells.

Authors:  Imen Nasri; Delphine Bonnet; Bailey Zwarycz; Emilie d'Aldebert; Sokchea Khou; Raoudha Mezghani-Jarraya; Muriel Quaranta; Corinne Rolland; Chrystelle Bonnart; Emmanuel Mas; Audrey Ferrand; Nicolas Cenac; Scott Magness; Laurianne Van Landeghem; Nathalie Vergnolle; Claire Racaud-Sultan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-06-16       Impact factor: 4.052

3.  Targeting PAR2 Overcomes Gefitinib Resistance in Non-Small-Cell Lung Cancer Cells Through Inhibition of EGFR Transactivation.

Authors:  Yuhong Jiang; Xin Zhuo; Xiujuan Fu; Yue Wu; Canquan Mao
Journal:  Front Pharmacol       Date:  2021-04-22       Impact factor: 5.810

4.  AURKA upregulation plays a role in fibroblast-reduced gefitinib sensitivity in the NSCLC cell line HCC827.

Authors:  Jia Chen; Huiqi Lu; Wang Zhou; Huabin Yin; Lishuang Zhu; Chang Liu; Pengfei Zhang; Huimin Hu; Yili Yang; Huanxing Han
Journal:  Oncol Rep       Date:  2015-01-29       Impact factor: 3.906

5.  Teleocidin A2 inhibits human proteinase-activated receptor 2 signaling in tumor cells.

Authors:  Sonja Stahn; Lisa Thelen; Ina-Maria Albrecht; Jens Bitzer; Thomas Henkel; Nicole Elisabeth Teusch
Journal:  Pharmacol Res Perspect       Date:  2016-06-10

6.  Proteinase-activated receptor-2 enhances Bcl2-like protein-12 expression in lung cancer cells to suppress p53 expression.

Authors:  Guoyuan Ma; Chao Wang; Baoyu Lv; Yuanzhu Jiang; Lei Wang
Journal:  Arch Med Sci       Date:  2019-08-02       Impact factor: 3.318

7.  PAR2 Promoter Hypomethylation Regulates PAR2 Gene Expression and Promotes Lung Adenocarcinoma Cell Progression.

Authors:  Kuan Wu; Lei Xu; Ling Cheng
Journal:  Comput Math Methods Med       Date:  2021-04-15       Impact factor: 2.238

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.